Although this product is not sold in the u.S.This event is being reported under regulation 21cfr part 803 as it involves a similar device to a pma approved device sold in the u.S.Under # p070014.The lot history have been reviewed with special attention to the mfg and inspection of this product and the product was found to have met all specs prior to shipment.During the eval of the returned delivery system, no device deficiency was detected.The deployment mechanism was fully functioning and no defect was found which may have led to a difficult stent deployment and subsequent stent elongation.As no images were provided, the reported stent elongation could not be confirmed.Potential factors which could have led or contributed to the reported event have been considered.Previous investigations of similar complaints have been reviewed.An inadvertent movement of the hand or incorrect holding of the delivery system during stent release, an insufficient pre-dilatation, highly calcified vessels, the pt's condition or the vessel anatomy may result in an irregular stent placement.On the basis of the info available and the eval of the sample, a definite root cause for the reported event could not be determined.The ifu supplied with this product sufficiently describes the correct application of the device.
|